Evidence map›Paper›PMID 42317819›Full record

ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2026

Trends in Telemedicine at a Cancer Center: Analyzing Sustained Use.

Fernanda C G Polubriaginof, Allison Lipitz-Snyderman, Susan Chimonas, Jennifer Prey Dawson, Gilad Kuperman

Abstract read
In one paragraph

Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fernanda C G PolubriaginofMemorial Sloan Kettering Cancer Center, New York, NY.
Allison Lipitz-SnydermanMemorial Sloan Kettering Cancer Center, New York, NY.
Susan ChimonasMemorial Sloan Kettering Cancer Center, New York, NY.
Jennifer Prey DawsonMemorial Sloan Kettering Cancer Center, New York, NY.
Gilad KupermanMemorial Sloan Kettering Cancer Center, New York, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telemedicine at a comprehensive cancer center evolved in the late-COVID-19 steady-state period. We retrospectively analyzed 3,761,467 ambulatory visits (2021-2024); 1,104,526 (29.4%) were telemedicine. Telemedicine's share declined from 33.1% in 2021 to 25.8% in 2024. Medicine services decreased from 35.7% to 28.4%, while Surgery rose from 13.5% to 15.1%. Adoption varied by service: Clinical Genetics (96.1%), Hematology (89.3%), Endocrinology (74.8%), and Infectious Disease (68.2%) remained high; Dermatology (4.9%) and Dental Surgery (0.1%) were low. Among surgical specialties, Hepatopancreatobiliary Surgery reached 41.6% (+14.4 points vs 2021). These findings indicate a durable hybrid care model, with sustained telemedicine in consultation-heavy services and limited use where examinations or procedures predominate. Factors influencing sustained use may include clinical appropriateness, and patient and clinician preferences. Results can inform digital health strategy, space planning, and policy decisions as national telehealth flexibilities evolve.

Identifiers

PMID42317819
PMCPMC13274306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.